Skip to main content
. 2022 Mar 15;30(1):150–162. doi: 10.38212/2224-6614.3400

Table 1.

Numbers of screening results for eight substructures.

Substructures Numbers (Double counting) Double counting drugs
DMA 122 (2) Dimazole, Cefotiam
DEA 38 Dimazole
DIPA 3 (1) Pramiracetam
IPEA 0
NMPa 3 Pramiracetam
MPA 0
DBA 4
Tetrazole 22 Cefotiam

Total 192
a

NMP is a root cause of MBA according to the EMA report 2019.